ReportWire

Tag: metastatic

  • Advanced Breast Cancer: What People Are Thinking

    Advanced Breast Cancer: What People Are Thinking

    [ad_1]

    The day-to-day realities of navigating advanced breast cancer are challenging enough. No need to add wondering what’s going through others’ heads. But understanding your loved ones’ thought process and where they’re coming from may make it easier to talk about your condition — and get the support you need. Here, we break down some of the most common questions, reactions, and thoughts. 

    You look too good to have metastatic cancer.

    When Natalie Hyman, 46, first began breast cancer treatment, it was obvious from her hair loss that she was going through chemotherapy. But when it returned more than a decade later as metastatic cancer, people were surprised to learn that she was ill. “People were puzzled because my treatment didn’t have any obvious visible signs: I wasn’t bald, I wasn’t throwing up, and I didn’t lose a lot of weight,” says Hyman, who lives in Kailua, HI. “But that doesn’t mean the drugs I was taking weren’t affecting my insides and making me feel lousy. You can look perfectly fine and still be battling metastatic cancer.”

    How could this have happened?

    In this era of early detection, it may be hard to believe that some women can be diagnosed with such late-stage breast cancer for which there’s no known cure. “There’s this unspoken belief by others that you weren’t vigilant enough, that you didn’t do something right,” says Sally Wolf, a New York City corporate wellness consultant who was diagnosed with metastatic breast cancer in 2017. “But since my mother had breast cancer when I was in high school, I’d been undergoing screening since I was 32. It still happened.”

    When will you be OK again?

    Your family and friends want you to get better because they love and care about you. But there’s no cure for metastatic breast cancer. “Metastatic breast cancer is a diagnosis that lasts a lifetime,” explains Wolf. “The best news that we can hope for is a scan that shows no evidence of disease.”

    Wolf notices this anytime she goes through a treatment for her cancer. “Initially, there’s an outpouring of support where people offer to accompany me for chemotherapy or stop by my apartment,” she says. “But after about 3 months, that stops.  Meanwhile, I’m still going to my treatments.”

    Part of the problem is what Raleigh, NC, resident Pam Kohl, 71, who was diagnosed with metastatic breast cancer in 2017, dubs as “toxic positivity.” “People don’t want to hear anything negative, and if they do, they dub you a Debbie downer,” says Kohl, who is executive director of Susan G. Komen, North Carolina Triangle to the Coast. “The reality of metastatic breast cancer is that at some point, you stop treatment and just focus on the quality of life you have left. Sometimes, folks don’t want to hear that.”

     

    Why do you seem so upset?

    Your friends may notice that you don’t seem like yourself but they aren’t sure what to do. “My temper is shorter at moments,” acknowledges Wolf. “I liken it to death by a thousand paper cuts. Someone does something stupid in the coffee line, and you’re like ‘Oh my God, really?!’” Wolf had a situation recently where she noticed a Starbucks staffer touching pastries with the same gloves she used to touch the register. “Most people wouldn’t think it’s a big deal. But as an immunocompromised person, I do, and it makes me really angry,” she says. 

    In addition, the day-to-day of metastatic cancer management becomes like a part time job. “I can tell people don’t understand why I’m so overwhelmed sometimes and can’t get through my to-do list,” says Wolf. “It’s because of the time and energy I spend dealing with mindboggling things.” Case in point: Recently, Wolf had a crucial appointment moved by an inexperienced administrative coordinator who didn’t bother checking with her oncologist first. “I managed to fix it, but it suddenly became a 45-minute urgent situation, and it was stressful,” says Wolf. “I spend hours trying to fix things like medical billing errors: things that aren’t my fault but directly affect me. It distracts me from all the other things I am supposed to do.”

    Do you want to talk about it?

    Not always. “Every time I go to a fundraiser or an event, people come up to me that I don’t know well and ask how I am. But I don’t always want to tell them. I live with stage IV metastatic breast cancer, and I do not always feel great,” says Kohl. “I’m not willing to be inauthentic. But people don’t want to hear the realities a lot of the time, especially when they are somewhere that encourages light chitchat.” 

    There’s a time and a place to talk about everything, including metastatic breast cancer, says Kohl. But sometimes, it’s better to speak about it somewhere other than at a schmoozy lunch. 

    I have no idea what you are going through.

    When someone is diagnosed with metastatic breast cancer, it’s life-altering. Even those close to you may have no clue what to say. “It’s hard to have a frame of reference if you have never experienced it,” says Jean Sachs, chief executive officer of Living Beyond Breast Cancer. 

    It’s up to you whether you want to bring your cancer up. You may find it exhausting to tell people about your illness repeatedly. But if it’s someone you’re very close to, realize that they may not always know what to say or may say the wrong thing. Just remember that they do care and want to be there for you in any way that they can.

    It’s OK to let them know you’ll reach out to them when you want to talk about it. It’s also OK to be clear that you don’t need to hear false optimism or how important it is to stay positive. “When they do that, they discount our very real fears, concerns, and feelings,” says Kohl. 

    [ad_2]

    Source link

  • NSCLC: Advances in Treatment

    NSCLC: Advances in Treatment

    [ad_1]

    Doctors once thought non-small-cell lung cancer (NSCLC) was one disease. Most people got the same treatment — chemotherapy (chemo) — especially if their cancer had spread to other parts of the body. 

    Now, doctors know there are many different types of NSCLC, with “more coming down the pike,” says Nathan Pennell, MD, a medical oncologist specializing in thoracic cancer at the Cleveland Clinic’s Taussig Cancer Institute.

    That means treatment plans are no longer once-size-fits-all. Instead, treatments like targeted therapies and immunotherapy are tailored to each person’s tumor.

    Targeted Therapies

    Some cancer cells have gene changes (also called mutations) that help them grow and spread. The goal of several targeted therapies is to block those changes. The FDA has approved medicines to treat eleven different gene mutations that can drive NSCLC:

    • EGFR
    • ALK
    • BRAF
    • ROS1
    • RET
    • MET
    • KRAS
    • PIK3CA
    • HER2
    • NTRK
    • MEK1

    One drug targets the growth of tumors on blood vessels:

    Epidermal growth factor receptor — or EGFR — is the most common. It’s a protein on the surface of cells that helps them grow and divide. If you have too much EGFR, your cells grow faster than normal.  Medicines called EGFR inhibitors stop this growth.    

    Karen Reckamp, MD, co-directs the lung cancer and thoracic oncology program at City of Hope in Duarte, CA. She says targeted therapy has completely changed the way doctors manage lung cancer. Now, before you start treatment for advanced NSCLC, you’re likely to have genetic testing to see if you have a mutation that might help guide your treatment.

    Reckamp says this new way of doing things has changed the game for many people with advanced NSCLC.

    “We don’t talk about a cure,” Reckamp says. “But the tumor shrinks, people feel better, go back to work, and have a better quality of life.”

    Targeted therapies also have drawbacks. Some only work for the small number of people who have gene mutations that respond to a certain targeted therapy. About 15% of people with lung cancer have EGFR-positive lung cancer. The numbers are much smaller for other gene changes.

    The medicines also have side effects, like:

    • Skin rash
    • Diarrhea
    • Liver damage
    • Bone marrow problems

    Reckamp says these usually aren’t as severe as side effects from chemotherapy.

    “For most people, the side effects are pretty tolerable, and they do pretty well.”

    Another problem is that targeted medicines often stop working, eventually.

    “Cancer cells find ways to survive and overcome the toxic treatments we’re giving them,” Reckamp says. “When that happens, you have to try a different treatment.” 

    Still, she says targeted therapies have greatly improved the odds for people with NSCLC.

    “With chemotherapy alone, [extending life] by 1 year was as good as we could get. Now, with these therapies in addition to chemo, it’s not uncommon for patients to live 2, or even 5 years.”

    Immunotherapy

    Your immune system normally destroys cancer cells. But tumor cells are sneaky and can find ways to evade your body’s best defenses. If you have NSCLC, some cancer cells may churn out a protein called PD-L1. It attaches to another protein, PD-1, on important immune T cells. This is called an immune checkpoint, and it tells your T cells to leave the tumor alone.  

    One way to get around this is with medicines called checkpoint inhibitors. They prevent PD-L1 and PD-1 from getting together. This unleashes your immune system, so it’ll be at full power against cancer cells. But healthy cells get caught in the crossfire.

    “Immunotherapy can cause inflammation anywhere in your body from head to toe,” Reckamp says. “When your immune system never turns off, you can get something resembling an autoimmune disease like rheumatoid arthritis. Or you can have problems with your thyroid, liver, bladder, kidneys, and heart.

    “And this can happen anytime — even after you’ve stopped treatment. But most symptoms can be well-controlled with high-dose steroids.”

    Your doctor won’t suggest immunotherapy unless your tumor tests positive for high levels of PD-L1. The test isn’t always correct, though, and some tumors that test positive for PD-L1 may not respond to immunotherapy.  

    Still, Reckamp says immunotherapy is a better choice than chemo for most people who have it, despite the severe side effects and hefty price tag. It may even keep working after you stop taking it.

    In the Pipeline

    Reckamp says to look for improvements in targeted medicines and smarter drugs that can outwit and outlast cancer cells.

    “There are lots of clinical trials focused on overcoming resistance to targeted medicines and immunotherapy, and combining these with chemotherapy to improve not just the length of a [person’s] life, but also the quality,” she says.

    [ad_2]

    Source link

  • NSCLC: Advances in Treatment

    NSCLC: Advances in Treatment

    [ad_1]




    NSCLC: Advances in Treatment

































    091e9c5e820faac4091e9c5e820faac4FED-Footermodule_FED-Footer_091e9c5e820faac4.xmlwbmd_pb_templatemodule0144002/02/2021 01:57:340HTML















    [ad_2]

    Source link

  • NSCLC: When You Need More Than One Treatment

    NSCLC: When You Need More Than One Treatment

    [ad_1]




    NSCLC: When You Need More Than One Treatment

































    091e9c5e820faac4091e9c5e820faac4FED-Footermodule_FED-Footer_091e9c5e820faac4.xmlwbmd_pb_templatemodule0144002/02/2021 01:57:340HTML















    [ad_2]

    Source link

  • NSCLC: When You Need More Than One Treatment

    NSCLC: When You Need More Than One Treatment

    [ad_1]

    Standard chemotherapy (chemo) was once the only treatment for advanced non-small-cell lung cancer (NSCLC). Now, you’re likely to get chemo plus a targeted medicine or immunotherapy, says Karen Reckamp, MD, co-director of the lung cancer and thoracic oncology program at City of Hope in Duarte, CA.

    She says most people need more than one therapy, and often, they get all three at some time during their treatment. Combined treatments may work better because they attack cancer in different ways. And while they aren’t likely to cure advanced NSCLC, they may help you live longer with fewer symptoms.

    Targeted Therapies

    These block gene changes that cause tumors to grow and spread. The meds are more precise in targeting tumors than chemo, so side effects may not be as tough to deal with.

    The problem is they often work for a while and then stop.  This may be because the gene changes again, so it’s no longer a good target. Or, cancer might find a way around the therapy. Either way, you’ll probably need to add another medicine — usually chemo or a different targeted drug.

    Immunotherapy

    This treatment works in a different way. It triggers your immune system to attack your cancer. If your tumor has a high level of the protein PD-L1, immunotherapy medicines called checkpoint inhibitors may be your best treatment. These often work better when combined with chemo.

    You May Still Need Chemo

    If you don’t have the PD-L1 protein or a gene target, immunotherapy plus chemo is likely to be your main treatment. Reckamp says that fact disappoints some people.

    “But we’re not at the point where we can do without [chemo],” she says. “In an era where we have all these new therapies, chemo is still helpful and will be part of most people’s treatment.”

    That’s because chemotherapy can mop up cancer cells that other treatments leave behind.

    “Metastatic cancer has spread through the lymph and blood to other places in the body,” Reckamp says. “That’s billions of cells. There’s always some cancer left, no matter what the treatment.”

    Dealing With Side Effects

    Cancer medicines can have serious side effects. What happens when you get two at the same time, or one right after the other? It can be tough, Reckamp says, especially since therapies can cause so many different problems.

    For example, platinum-based chemo — the kind used for advanced NSCLC — damages all your fast-growing cells, even the healthy ones. Common side effects are:

    • Nausea
    • Diarrhea
    • Hair loss
    • Anemia
    • Bleeding

    Chemo also can cause liver and kidney damage. If your side effects are severe, you may need a lower dose, or to stop treatment completely. Reckamp says many people can predict how they’re going to feel on certain days and plan around it. And since chemo is given in cycles, you have a chance to rest during the breaks.

    You may not get a break from certain targeted medicine, though.  Many targeted medicines are taken every day. That makes you more likely to have constant, but manageable symptoms, like rashes and diarrhea.

    “You might have one really bad day of diarrhea with chemo and mild diarrhea every day with a targeted therapy,” Reckamp says.

    Targeted medicines usually won’t make you as tired as chemo. Other side effects are usually easier on your body, too, but they still need to be dealt with.

    “All these drugs are attacking cancer, so there is a level of not feeling like yourself,” Reckamp says. “Most people get used to that feeling. When they stop treatment, they remember what they’re supposed to feel like.”

    What about side effects from immunotherapy, which can be pretty unpredictable?

    “That’s anyone’s guess,” Reckamp says. “It can cause inflammation anywhere in your body at any time, even after you stop treatment. You can get inflammation in the brain, colon, thyroid gland, liver, bladder, kidneys, or heart.

    “We can predict when you’ll feel bad with chemotherapy, but with immunotherapy, we can’t.”

    She says people who get both immunotherapy and chemo need to be on high alert. The number of possible side effects is high, and some can come without warning.

    “If you’re not feeling like yourself, call your doctor, and they can help guide you what to do next,” she advises. “Also, [very serious] problems like colitis and pneumonitis [lung inflammation] can happen quickly and suddenly. We need to hear about that right away.”

    Scott Gettinger, MD, an expert in immunotherapy and targeted therapy at Yale Cancer Center in New Haven, CT, also warns about pneumonitis. It’s inflammation of lung tissue that can cause cough and shortness of breath. For people with NSCLC, it can be deadly.

    “When you suspect pneumonitis, you need to start steroids right away,” he says.

    High-dose steroids can bring down life-threatening inflammation. Lower doses may help treat less serious symptoms.

    Despite the intense side effects, Reckamp says most people do pretty well with combined treatments.

    “You can work, travel, and live a fairly normal life, but you need to adjust for days when you don’t feel well,” she explains. “Hospitals and treatment centers have social workers and many other resources to help you get back into life.”

    But, Reckamp says, you’ll also need help you can’t get from a hospital.

    “You also need strong social support from your family,” she says.  “And it can be helpful to join a group of like-minded people or talk to a therapist or counselor.

    “Patients are living longer, so it’s important to help them figure out how to frame what they want for their lives and how to do what they want to do.”

    [ad_2]

    Source link